Abstract : The purpose of this study was to review the best available evidence of noninvasive brain stimulation, including repetitive transcranial magnetic stimulation (rTMS) and transcranial direct current stimulation (tDCS) for dysphagia after acquired brain injury. We searched randomized controlled trials that compared noninvasive brain stimulation with control used to improve dysphagia after acquired brain injury. We assessed dysphagia severity rating scales and penetration-aspiration scale as outcomes immediately after intervention. We calculated the pooled estimate of the standardized mean difference (SMD) to combine individual results. We included 8 published studies. Two heterogenous trials of 48 patients showed that rTMS was associated with a significant improvement in the dysphagia severity rating scale score (SMD 2.95). Three homogeneous trials of 88 patients showed a significant effect of rTMS on the penetration -aspiration scale score (SMD 0.77). Two homogeneous trials of 34 patients showed that tDCS was associated with a significant improvement in the dysphagia severity rating scale score (SMD 1.20). The review provided low-quality evidence for the effectiveness of noninvasive brain stimulation in improving dysphagia after acquired brain injury. Further trials of larger sample sizes are needed to determine the most appropriate noninvasive brain stimulation protocol. J. Med. Invest. 63 : 153-158, August, 2016
INTRODUCTION
Acquired brain injury (ABI), including stroke and traumatic brain injury, is a potentially serious condition that frequently results in disability requiring rehabilitation (1) . Dysphagia is a common complication in ABI patients and is a major cause of aspiration pneumonia and malnutrition. Dealing with dysphagia is clinically important because it can affect the quality of life and prognosis of ABI patients.
In recent years, the noninvasive brain stimulation (NBS) methods of repetitive transcranial magnetic stimulation (rTMS) and transcranial direct current stimulation (tDCS) have been used for patients with ABI as a therapeutic neuromodulation tool (2) . RTMS is a painless, noninvasive method that modulates cortical excitability. High-frequency rTMS facilitates cortical excitability, while low-frequency rTMS decreases cortical excitability of the stimulated hemisphere and increases cortical excitability of the nonstimulated hemisphere (3) . TDCS is a non-invasive method used to modulate cortical excitability by applying direct current to the brain. During stimulation, the anode electrode causes enhancement of cortical excitability while the cathode electrode generates the opposite effect (4) .
Several randomized controlled trials (RCTs) of NBS for dysphagia have been published in recent years (5 -7) . A systematic review of trials examining the efficacy and acceptability of NBS would be informative and useful for clinicians and researchers. Thus, the purpose of this study was to review the best available evidence of noninvasive brain stimulation for post-acquired brain injury dysphagia systematically, and to show the future direction of research in this field.
MATERIALS AND METHODS

Types of studies
We included only RCTs in this meta-analysis and excluded quasiRCTs and randomized controlled cross-over trials. Abstracts and non-English language publications were also excluded.
Types of participants
We included patients of any gender and older than 18 years of age with ABI of a non-degenerative nature. This included traumatic brain injury and stroke regardless of the duration of disease or severity of the disability. We excluded any condition of a progressive nature.
Types of interventions and comparisons
We included NBS (rTMS or tDCS) therapy alone or NBS plus rehabilitation. We excluded NBS plus peripheral electrical stimulation. The control interventions were sham treatment, sham treatment plus rehabilitation or no intervention. We excluded peripheral electrical stimulation.
Outcomes
We assessed outcomes at the time immediately after intervention. The primary outcomes were the Dysphagia Severity Rating Scales (Functional Oral Intake Scale : FOIS (8), Dysphagia Outcome Severity Scale : DOSS (9), Food Intake LEVEL Scale : FILS (10)). The secondary outcome was the penetration -aspiration scale : PAS (11) based on videofluoroscopy or videoendoscopic examination. 
Selection of studies
Two authors (RM and SK) independently reviewed all potential studies for inclusion against the eligibility criteria. They examined the title and abstract and, where necessary, the full text of studies to assess if they are eligible for inclusion. If they could not reach agreement by discussion, a third author (NY) made the final decision about eligibility.
Data extraction
Two authors (RM and SK) used a standard form to extract study characteristics and outcome data from the studies independently. Discrepancies were checked against the original data. A third author (NY) made the final decision in case of disagreement. One author (RM) entered the data in Review Manager (RevMan) meta-analysis software Version 5. 
Assessment of risk of bias
We assessed the methodological quality of selected studies as described in the Cochrane Review Groups (12) . We created a Risk of bias table and included description and judgment (low risk of bias, high risk of bias, or unclear risk of bias) for the following domains for each of the included studies : 1. random sequence generation ; 2. allocation concealment ; 3. blinding of participants and personnel ; 4. blinding of outcome assessment ; 5. incomplete outcome data ; 6. selective reporting ; 7. other sources of bias. Two review authors independently performed quality assessment. Any disagreement between authors arising at any stage was resolved through discussion or through a third author.
Statistical analysis
For all outcomes related to continuous data, we calculated a pooled estimate of the standardized mean difference (SMD) with 95% confidence interval (CI). We used a generic inverse variance method and random effects model to combine individual results. The threshold for significance was set at p!0.05. For all statistical comparisons we used RevMan 5.3. We used the I 2 statistic to assess heterogeneity. I 2 "50% was considered to reflect substantial heterogeneity (13) . We used the funnel plot method for assessment of reporting biases only when there were at least 10 studies included in the meta-analysis (14) . Statistical analysis was conducted by dividing NBS into rTMS or tDCS. We used the criteria of the Grading of Recommendations Assessment, Development and Evaluation (GRADE) to evaluate the quality of the evidence by outcome. This study was prospectively registered with the PROSPERO database of systematic reviews (CRD42015032269)
RESULTS
Results of the search
We identified 291 records through the searches after removal of duplicates. After screening the titles and abstracts, we excluded 163 records mainly because the studies were animal studies, abstracts only and non-English language publications. After further assessment, 8 studies (5 rTMS and 3 tDCS studies) were considered to meet the review inclusion criteria ( Figure 1 ).
Characteristics of patients
The meta-analysis was based on 8 studies (15 -22) that included 188 patients. Table 1 provides a comprehensive summary of the 8 studies. The mean age of participants ranged from 57 to 75 years. The proportion of women was 27% to 65% among these trials. Most studies did not include information on ABI severity or activities of daily living. All studies included data on stroke (infarction or hemorrhage) except for one study, which included patients with TBI (2 participants) (17) . Almost all patients had unilateral cerebral hemisphere damage. However, two studies included patients with infratentorial lesions (16, 22) . The severity of dysphagia ranged between moderate and severe. Almost all trials included patients with acute to sub-acute phase stroke (up to 3 months from onset), although one study included chronic patients (more than six months from onset) (22) . The follow-up period ranged from 1 to 90 days after the end of intervention.
Interventions
Trials were divided into three categories based on the intervention : 1. rTMS compared with sham rTMS (15, 16, 18) ; 2. rTMS with swallowing exercise compared with sham rTMS with swallowing exercise (17, 19) ; and 3. tDCS with swallowing exercise compared with sham tDCS with swallowing exercise (20 -22) . The frequency of rTMS ranged from 1 to 5 Hz. TDCS was applied using 1 or 2 mA. Stimulation was applied to the ipsilateral, contralateral or bilateral motor area. The treatment protocols included 5-10 sessions, with each including the application of stimulation for 10 -30 min/day.
Outcome measures
Four trials (15, 16, 20, 22) used DOSS and 3 trials (17 -19) used PAS for assessment of outcome. Other reported outcome measures included Functional Dysphagia Scale : FDS (23), American Speech-Language -Hearing Association National Outcome Measurement System swallowing scale : ASHS NOMS swallowing scale (24), Videofluoroscopic Dysphagia Scale : VDS (25) and Pharyngeal Transit Time : PTT (26) . All trials included the outcomes at the end of treatment period. We excluded one trial from qualitative synthesis (21) because it did not provide appropriate outcome data.
Risk of bias
Next, we analyzed the risk of bias in characteristics of included studies. For this purpose, we drew risk of bias summary based on each risk of bias item presented as percentages across all included studies (Figure 2 ). The method of allocation concealment was not described or not described in sufficient detail to allow a definite judgment in 6 studies. Because complete blinding to sham rTMS is difficult in such studies, we judged that all studies using rTMS involved high risk of bias for blinding of participants and personnel. All of the included studies were low risk of bias for incomplete outcome data. Some studies had a few missing outcome data, although these balanced in numbers across the intervention groups, with similar reasons for missing data across groups. There was insufficient information to make judgment on selective reporting. One study completed trial registration before the study and thus conformed low risk of selective reporting (20) . The number of studies was insufficient to employ funnel plot analysis. 
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Effects of interventions Comparison : rTMS versus control
With regard to the primary outcome, two trials with 48 participants recorded DOSS immediately after intervention. Meta-analysis showed that rTMS intervention was associated with a significant improvement in DOSS (SMD : 2.95, 95% CI : 1.02-4.88, P=0.003). However, there was statistically significant heterogeneity between the trials (I 2 = 77%) ( Figure 3 ). Three trials that included 88 patients recorded PAS immediately after the intervention. Meta-analysis showed that rTMS intervention was associated with a significant improvement in PAS (SMD : 0.77, 95% CI : 0.33 -1.21, P= 0.0006). There was no statistically significant heterogeneity between the trials (I 2 = 0%) (Figure 4) .
Comparison : tDCS versus control
With regard to the primary outcome, two trials with 34 participants recorded DOSS immediately after intervention. Meta-analysis showed that tDCS intervention was associated with a significant improvement in DOSS (SMD : 1.20, 95% CI : 0.45 -1.95, P= 0.002). There was no statistically significant heterogeneity between the trials (I 2 = 0%) ( Figure 5 ). There were no studies concerning tDCS for PAS. 
DISCUSSION
This review focused on evaluating the best available evidence of rTMS or tDCS versus control for improvement of swallowing function after ABI. We included 8 trials that included 188 patients. Two studies of 48 patients using rTMS and two studies of 34 patients using tDCS examined the effects on the primary outcome measure selected in our study ; the Dysphagia Severity Rating Scale after ABI. We found evidence of a favorable effect of rTMS and tDCS on DOSS at the end of the intervention. Three studies of 88 participants assessed the effects of rTMS on PAS at the end of intervention and there was significant evidence for the effect at the end of the intervention.
Overall completeness and applicability of evidence
The results of the review were limited by the following factors. First, the stimulation protocol (frequency, pulses, target of stimulation) varied across studies. Therefore, we were unable to select the most suitable rTMS and tDCS protocol. Second, most participants suffered from supratentorial stroke in acute or subacute phage. Thus, the results may be of limited value to patients with infratentorial lesion, chronic stroke or traumatic brain injury. Third, the longest follow-up period was 3 months. Thus, the long-term effect of the interventions remains unclear at this stage. Forth, we did not cover trials that are still unpublished or in press, published in non-English languages or published in abstracts only. The above limitations/study protocol point to some potential bias in the review process. Fifth, the total number of studies was small. Therefore, it may be too early to perform meta-analysis for this topic. However, the aim of this study was to review the best available evidence to show the future direction of research. If the number of studies is small, it is still meaningful to combine the best available evidence. Almost all Cochrane review groups follow such a standardized editorial and publishing policy. We followed a similar policy. Furthermore, we registered the analysis protocol to combine the best available evidence. The policy safeguards against changing the analysis and reporting depending on the results (that is breaking the protocol), and introducing selective reporting bias. For these reasons, we conducted meta-analysis according to our registered protocol.
Quality of evidence
In general, the quality of reporting was poor. Most trials reported random assignment but the methods of randomization were not described in full detail. Compared with rTMS and tDCS, sham rTMS is harder to perform than sham tDCS with regard to blinding of participants and personnel. Although all trials used sham rTMS in the control group, the success of blinding was not recorded. There was large heterogeneity between the studies, particularly for rTMS. The potential problem associated with this heterogeneity relates to the affected brain region ; supra-and infratentorial areas. The sample size was small, ranging from 14 to 40 patients, and the number of studies was not sufficient to assess publication bias. Thus, we call for large RCTs to verify the efficacy of rTMS and tDCS for dysphagia.
Conclusions
Low quality evidence suggests the efficacy of rTMS and tDCS in improving dysphagia after ABI. This evidence, however, needs to be substantiated and confirmed. Routine use of NBS in patients 
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with ABI should be avoided until its efficacy is verified in highquality, large -scale RCTs.
There are some ongoing clinical trials in this field (tDCS : ISRCTN97286108, rTMS : NCT02090231). Future studies with large sample size that include patients with infra-and supra-tentorial lesions and acute and chronic stroke are needed to validate the beneficial effects of NBS for dysphagia. Particularly, the most suitable rTMS and tDCS protocol should be defined and functional outcome measured at long-term follow-up should be used as the primary outcome.
